Comments on: Avineuro Pharmaceuticals, Inc. reports positive Phase I clinical trial results on AVN-322, potent small molecule for treatment of Alzheimer’s disease.

Comments on: Avineuro Pharmaceuticals, Inc. reports positive Phase I clinical trial results on AVN-322, potent small molecule for treatment of Alzheimer’s disease. http://www.avineuro.com/avineuro-pharmaceuticals-inc-reports-positive-phase-i-clinical-trial-results-on-avn-322-potent-small-molecule-for-treatment-of-alzheimer%e2%80%99s-disease/ Avineuro Pharmaceuticals hourly 1 https://wordpress.org/?v=4.2.38